CD40LG and Hepatitis: Anti-AAV2 IgM was detected in 15 out of 23 (65.2%) samples from cases of hepatitis, but only 1 out of 13 (7.7%) samples from group 1 healthy controls and 2 out of 16 (12.5%) samples from the group 4 contemporaneous controls from Scotland.